119 related articles for article (PubMed ID: 18812065)
21. Genital herpes simplex infections in patients with the acquired immunodeficiency syndrome.
McGrath BJ; Newman CL
Pharmacotherapy; 1994; 14(5):529-42. PubMed ID: 7997387
[TBL] [Abstract][Full Text] [Related]
22. Short-course therapy for recurrent genital herpes and herpes labialis.
Spruance S; Aoki FY; Tyring S; Stanberry L; Whitley R; Hamed K
J Fam Pract; 2007 Jan; 56(1):30-6. PubMed ID: 17217895
[No Abstract] [Full Text] [Related]
23. Genital herpes due to acyclovir-sensitive herpes simplex virus caused secondary and recurrent herpetic whitlows due to thymidine kinase-deficient/temperature-sensitive virus.
Shimada Y; Suzuki M; Shirasaki F; Saito E; Sogo K; Hasegawa M; Takehara K; Phromjai J; Chuhjo T; Shiraki K
J Med Virol; 2007 Nov; 79(11):1731-40. PubMed ID: 17854045
[TBL] [Abstract][Full Text] [Related]
24. Genital lesions in a woman with AIDS.
Ravishankar J; Liu M; Lynfield Y
AIDS Read; 2005 Sep; 15(9):457-8. PubMed ID: 16170874
[No Abstract] [Full Text] [Related]
25. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.
Safrin S; Crumpacker C; Chatis P; Davis R; Hafner R; Rush J; Kessler HA; Landry B; Mills J
N Engl J Med; 1991 Aug; 325(8):551-5. PubMed ID: 1649971
[TBL] [Abstract][Full Text] [Related]
26. Herpes. Atypical clinical manifestations.
Tyring SK; Carlton SS; Evans T
Dermatol Clin; 1998 Oct; 16(4):783-8, xiii. PubMed ID: 9891681
[TBL] [Abstract][Full Text] [Related]
27. Management of genital herpes infection.
Lavoie SR; Kaplowitz LG
Semin Dermatol; 1994 Dec; 13(4):248-55. PubMed ID: 7848818
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of a new point-of-care serologic assay for herpes simplex virus type 2 infection.
Philip SS; Ahrens K; Shayevich C; de la Roca R; Williams M; Wilson D; Bernstein K; Klausner JD
Clin Infect Dis; 2008 Nov; 47(10):e79-82. PubMed ID: 18840082
[TBL] [Abstract][Full Text] [Related]
29. [Acyclovir-resistant Herpes simplex viruses in HIV-infected patients].
Baumann R; Wunderli W; Riess C; Vogt M
Schweiz Med Wochenschr; 1993 Dec; 123(51-52):2394-400. PubMed ID: 8290931
[No Abstract] [Full Text] [Related]
30. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
[TBL] [Abstract][Full Text] [Related]
31. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection.
Wald A; Carrell D; Remington M; Kexel E; Zeh J; Corey L
Clin Infect Dis; 2002 Apr; 34(7):944-8. PubMed ID: 11880960
[TBL] [Abstract][Full Text] [Related]
32. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.
Gray R; Wilson D
N Engl J Med; 2010 May; 362(18):1740; author reply 1741-2. PubMed ID: 20445189
[No Abstract] [Full Text] [Related]
33. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.
Bavaro JB; Drolette L; Koelle DM; Almekinder J; Warren T; Tyring S; Wald A
Sex Transm Dis; 2008 Apr; 35(4):383-6. PubMed ID: 18362859
[TBL] [Abstract][Full Text] [Related]
34. Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection.
Celum CL; Robinson NJ; Cohen MS
J Infect Dis; 2005 Feb; 191 Suppl 1():S107-14. PubMed ID: 15627220
[TBL] [Abstract][Full Text] [Related]
35. Case report: symptomatic oral herpes simplex virus type 2 and asymptomatic genital shedding.
Olin L; Wald A
Herpes; 2006 May; 13(1):25-6. PubMed ID: 16733000
[TBL] [Abstract][Full Text] [Related]
36. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
Tyring SK; Baker D; Snowden W
J Infect Dis; 2002 Oct; 186 Suppl 1():S40-6. PubMed ID: 12353186
[TBL] [Abstract][Full Text] [Related]
37. Genital ulcer disease treatment policies and access to acyclovir in eight sub-Saharan African countries.
Corbell C; Stergachis A; Ndowa F; Ndase P; Barnes L; Celum C
Sex Transm Dis; 2010 Aug; 37(8):488-93. PubMed ID: 20539260
[TBL] [Abstract][Full Text] [Related]
38. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.
Ruark AH; Shelton JD; Halperin DT
N Engl J Med; 2010 May; 362(18):1741; author reply 1741-2. PubMed ID: 20449879
[No Abstract] [Full Text] [Related]
39. [Ulcerative herpes simplex as the first manifestation of AIDS].
Bundino S; Barberis L; Zina AM
G Ital Dermatol Venereol; 1990 Jun; 125(6):291-3. PubMed ID: 2279760
[TBL] [Abstract][Full Text] [Related]
40. HSV-2 and HIV: consequences of an endemic opportunistic infection.
Wald A; Schacker T; Corey L
STEP Perspect; 1997; 9(3):2-4. PubMed ID: 11364936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
